Flagship Pioneering unfurls cell signaling company Sonata Therapeuticsnews2022-05-18T13:39:25+00:00May 18th, 2022|FierceBiotech|
Barber buzzes into Aquestive CEO post as Kendall leaves amid FDA delaynews2022-05-18T12:36:20+00:00May 18th, 2022|FierceBiotech|
With lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series Bnews2022-05-18T11:30:16+00:00May 18th, 2022|FierceBiotech|
Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse eventsnews2022-05-17T19:06:06+00:00May 17th, 2022|FierceBiotech|
UPDATE: Pfizer, Sarepta team with fellow DMD gene therapy makers to get to the bottom of adverse eventsnews2022-05-17T19:06:06+00:00May 17th, 2022|FierceBiotech|
FDA has change of heart, plans to convene advisory meeting for Cytokinetics’ cardiac mednews2022-05-17T14:35:13+00:00May 17th, 2022|FierceBiotech|
Ampio’s years of troubles come to a head with internal investigation, trio of COVID trial failuresnews2022-05-17T13:18:54+00:00May 17th, 2022|FierceBiotech|
Scholar Rock in a hard place as biotech lays off 25% of staff, narrows pipeline and loses CMOnews2022-05-17T13:15:24+00:00May 17th, 2022|FierceBiotech|
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D centernews2022-05-17T11:34:14+00:00May 17th, 2022|FierceBiotech|
AstraZeneca bags pan-variant COVID-19 antibodies from stealthy biotech in $157M dealnews2022-05-17T10:06:04+00:00May 17th, 2022|FierceBiotech|
